Skip to main navigation
Healthcare Providers in the U.S. can now  begin prescribing AspyreRx
logo
  • Overview
  • News & Events
    • Press Releases
    • Presentations & Events
  • Stock
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Governance
    • Documents & Charters
    • Board of Directors
    • Leadership
    • Committee Composition
    • Financial Concern Hotline
    • Code of Conduct Hotline
  • Financials
    • SEC Filings
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Contact

SEC Filing Details

Document Details

Form
8-K/A
Filing Date
Jan 14, 2022
Document Date
Nov 19, 2021
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
Better Therapeutics, Inc
Issuer
BETTER THERAPEUTICS, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT
Better therapeutics black bg - no clear space

Investor Relations

News & Events Press Releases Presentations & Events
Stock Stock Quote & Chart Historic Price Lookup Investment Calculator Analyst Coverage
Governance Documents & Charters Board of Directors Leadership Committee Composition Financial Concern Hotline Code of Conduct Hotline
Financials SEC Filings
Investor Resources Investor FAQs Email Alerts Contact
© Better Therapeutics, Inc       

Footer Terms Policy Links

Terms      Privacy     

Footer Social Links

Facebook Instagram LinkedIn Twitter
x
Exit

You are leaving Better Therapeutics, Inc. website. You may return to Better Therapeutics, Inc. website by using the back button on your web browser toolbar or closing the window to the third-party website that you have opened. Do you wish to continue?

YES NO